Viladomiu L - Search Results

1

Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.

Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA, Bartolome J, Esteban R, Guardia J. Buti M, et al. Among authors: viladomiu l. Am J Nephrol. 1992;12(3):144-7. doi: 10.1159/000168436. Am J Nephrol. 1992. PMID: 1415374

2

Hepatitis E virus infection in acute hepatitis in Spain.

Buti M, Jardí R, Cotrina M, Rodríguez-Frías F, Troonen H, Viladomiu L, Esteban JI, Esteban R, Guardia J. Buti M, et al. Among authors: viladomiu l. J Virol Methods. 1995 Sep;55(1):49-54. doi: 10.1016/0166-0934(95)00044-u. J Virol Methods. 1995. PMID: 8576308

3

Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.

Genesca J, Esteban JI, Quer J, Viladomiu LL, Gonzalez A, Esteban R, Guardia J. Genesca J, et al. Among authors: viladomiu ll. Gut. 1993;34(2 Suppl):S62-3. doi: 10.1136/gut.34.2_suppl.s62. Gut. 1993. PMID: 7686120 Free PMC article. Clinical Trial.

4

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial.

Viladomiu L, Genescà J, Esteban JI, Allende H, González A, López-Talavera JC, Esteban R, Guardia J. Viladomiu L, et al. Hepatology. 1992 May;15(5):767-9. doi: 10.1002/hep.1840150504. Hepatology. 1992. PMID: 1568716 Clinical Trial.

5

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.

Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, et al. Esteban JI, et al. Among authors: viladomiu l. N Engl J Med. 1990 Oct 18;323(16):1107-12. doi: 10.1056/NEJM199010183231605. N Engl J Med. 1990. PMID: 2170839 Free article.

6

Hepatitis C virus antibodies among risk groups in Spain.

Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genescà J, Buti M, et al. Esteban JI, et al. Among authors: viladomiu l. Lancet. 1989 Aug 5;2(8658):294-7. doi: 10.1016/s0140-6736(89)90485-6. Lancet. 1989. PMID: 2569102

7

Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations.

Rodriguez-Frias F, Buti M, Jardi R, Cotrina M, Viladomiu L, Esteban R, Guardia J. Rodriguez-Frias F, et al. Among authors: viladomiu l. Hepatology. 1995 Dec;22(6):1641-7. doi: 10.1002/hep.1840220605. Hepatology. 1995. PMID: 7489968

8

Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?

Buti M, Jardi R, Allende H, Cotrina M, Rodriguez F, Viladomiu L, Esteban R, Guardia J. Buti M, et al. Among authors: viladomiu l. J Med Virol. 1996 May;49(1):66-9. doi: 10.1002/(SICI)1096-9071(199605)49:1<66::AID-JMV11>3.0.CO;2-0. J Med Virol. 1996. PMID: 8732862

9

When should at-risk infants be boosted with hepatitis B vaccine?

Viladomiu L, Genesca J, Esteban JI, Esteban R, Hernandez JM, Guardia J. Viladomiu L, et al. Lancet. 1987 Jan 3;1(8523):49. doi: 10.1016/s0140-6736(87)90748-3. Lancet. 1987. PMID: 2879136 No abstract available.

10

Utility of early testing for HCV viremia as predictive factor of sustained response during interferon or interferon plus ribavirin treatment.

Castro FJ, Esteban JI, Sauleda S, Viladomiu L, Dragon EA, Esteban R, Guardia J. Castro FJ, et al. Among authors: viladomiu l. J Hepatol. 2000 May;32(5):843-9. doi: 10.1016/s0168-8278(00)80255-x. J Hepatol. 2000. PMID: 10845673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters